CoChat

Construction and Validation of a Potent Epigenetic Modification-Related Prognostic Signature for Osteosarcoma Patients

Open access
Liu, Siyu, Wu, Bing, Li, Xiaomin, Zhao, Lulu, Wu, Wen, Ai, Songtao · 2021 · Journal of Oncology

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Background. Increasing evidence has shown that tumorigenesis correlates with aberrant epigenetic factors, such as DNA methylation, histone modification, RNA m6A modification, RNA binding proteins, and transcription factors. However, it is unclear that how epigenetic genes linked with alteration contribute to osteosarcoma’s incidence and clinical prognosis. We developed an epigenetic modification-related prognostic model that may improve the diagnosis and prognosis of osteosarcoma. Methods. We investigated the epigenetic modification-associated genes and their clinical significance in osteosarcoma in this research. Our gene transcriptome data were obtained from the TARGET database and the GEO database. Bioinformatics techniques were used to investigate their functionalities. The diagnostic and prognostic models were constructed using univariate and multivariate Cox regression. In addition, we developed a nomogram indicating the practicability of the prognostic model described above. Results. A risk score model constructed based on four epigenetic modification-related genes (MYC, TERT, EIF4E3, and RBM34) can effectively predict the prognosis of patients with osteosarcoma. Based on the risk score and clinical features, we constructed a nomogram. Conclusion. Epigenetic modification-related genes have been identified as important prognostic markers that may assist in osteosarcoma therapy therapeutic decision-making.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2021/2719172

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Whole procedures for analyzing EMGs in osteosarcoma.
Figure 1 Whole procedures for analyzing EMGs in osteosarcoma.CC BY · PubMed Central
Figure 2 The differentially expressed EMGs in osteosarcoma. (a) Heat map. (b) Volcano plot.
Figure 2 The differentially expressed EMGs in osteosarcoma. (a) Heat map. (b) Volcano plot.CC BY · PubMed Central
Figure 3 KEGG pathway and GO enrichment analysis of aberrantly expressed EMGs. (a) Upregulated EMGs. (b) Downregulated EMGs.
Figure 3 KEGG pathway and GO enrichment analysis of aberrantly expressed EMGs. (a) Upregulated EMGs. (b) Downregulated EMGs.CC BY · PubMed Central
Figure 4 PPI network construction and identification of key modules. (a) PPI network of differently expressed EMGs; (b–d) critical module from the PPI network.
Figure 4 PPI network construction and identification of key modules. (a) PPI network of differently expressed EMGs; (b–d) critical module from the PPI network.CC BY · PubMed Central
Figure 5 Risk score analysis of four-genes prognostic model in TARGET and GEO cohort. (a), (c), (e) (g), and (i) represent TARGET cohort; (b), (d), (f), and (h) represent GEO cohort. (a, b) Survival curve for low- and high-risk groups. (c, d) Survival status of low- and high-risk groups. (e, f) The mean value and distribution of the risk score. (g, h) Expression heat map. (i, j) ROC curves.
Figure 5 Risk score analysis of four-genes prognostic model in TARGET and GEO cohort. (a), (c), (e) (g), and (i) represent TARGET cohort; (b), (d), (f), and (h) represent GEO cohort. (a, b) Survival curve for low- and high-risk groups. (c, d) Survival status of low- and high-risk groups. (e, f) The mean value and distribution of the risk score. (g, h) Expression heat map. (i, j) ROC curves.CC BY · PubMed Central
Figure 6 Cox regression analyses for the risk score. Univariate and multivariate analysis for (a, c) TARGET dataset; (b, d) GEO dataset.
Figure 6 Cox regression analyses for the risk score. Univariate and multivariate analysis for (a, c) TARGET dataset; (b, d) GEO dataset.CC BY · PubMed Central
Figure 7 The risk score in two groups divided by clinical characteristics. (a–c) TARGET dataset; (d–f) GEO dataset.
Figure 7 The risk score in two groups divided by clinical characteristics. (a–c) TARGET dataset; (d–f) GEO dataset.CC BY · PubMed Central
Figure 8 Nomogram for predicting OS of osteosarcoma patients in TARGET cohort. (a) Predictive nomogram. (b–d) Calibration curve.
Figure 8 Nomogram for predicting OS of osteosarcoma patients in TARGET cohort. (a) Predictive nomogram. (b–d) Calibration curve.CC BY · PubMed Central
Figure 9 GSEA analysis. (a) KEGG, (b) GO, and (c) Hallmark gene set.
Figure 9 GSEA analysis. (a) KEGG, (b) GO, and (c) Hallmark gene set.CC BY · PubMed Central
Figure 10 Relationship between the prognostic EMGs and drug sensitivity.
Figure 10 Relationship between the prognostic EMGs and drug sensitivity.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

Metadata

Authors
Liu, S., Wu, B., Li, X., Zhao, L., Wu, W., & Ai, S.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
Ai, Songtao
Venue
Journal of Oncology
Publisher
Wiley
Published
2021-11-22
Volume
2021
Pages
1-14
ISSN
  • 1687-8450 (ISSN-L)
  • 1687-8469
OpenAlex
W3215576535
Cited by
15
References
35
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 4
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Journal of Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
osteosarcoma, epigenetic modifications, prognostic signature, risk scoring, nomogram, c-Myc, telomerase reverse transcriptase, EIF4E3, DNA methylation, histone modifications, m6A RNA methylation, RNA-binding proteins, transcription factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.